Polar Capital Holdings PLC Laboratory Corp Of America Holdings Transaction History

Polar Capital Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $2.33 Million - $3.03 Million	-10,903 Reduced 38.97%	17,072 $4 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $490,799 - $563,262	-1,889 Reduced 6.33%	27,975 $7.38 Million
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $289,525 - $334,947	-1,066 Reduced 3.45%	29,864 $9.38 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $134,936 - $151,394	491 Added 1.61%	30,930 $8.71 Million
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $2.89 Million - $3.19 Million	11,482 Added 60.57%	30,439 $8.4 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $234,177 - $291,499	-1,143 Reduced 5.69%	18,957 $4.84 Million
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $3.76 Million - $4.31 Million	20,100 New	20,100 $4.09 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.